2.
Buchanan T, Xiang A, Peters R, Kjos S, Marroquin A, Goico J, Ochoa C, Tan S, Stanley P. Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone. In: Diabetes. AMER DIABETES ASSOC 1660 DUKE ST, ALEXANDRIA, VA 22314 USA, 2001;pp. A81-A81.